Interactive Transcript
0:01
Hello and welcome to noom Conference, hosted by MRI Online
0:05
Noon Conference connects the global radiology community
0:07
through free live educational webinars that are accessible
0:10
for all and is an opportunity
0:12
to learn alongside top radiologists from around the world.
0:16
You can access a recording of today's conference
0:18
and previous noom conferences
0:19
by creating a free MRI online account.
0:23
Today we are honored to welcome Dr.
0:25
Mahan Mather for a GI G case review. Since 2013, Dr.
0:29
Mather has served his faculty at the Yale School
0:32
of Medicine, where he's an associate professor of radiology
0:34
and biomedical imaging and vice chair of education.
0:38
He's passionate about radiology education and mentorship,
0:41
and has been the recipient of the RSNA Honored Educator
0:43
Award in 2017
0:45
and 2021, as well as numerous departmental teacher
0:48
and mentor of the year awards.
0:50
We're also thankful for his supportive MRI align
0:53
and for serving as our body imaging advisor.
0:55
In this interactive session, Dr.
0:57
Mather will show key images along
0:59
with a multiple choice question,
1:00
and you'll respond with your best answer via
1:02
the live polling feature.
1:04
After a quick answer explanation, it's onto the next case.
1:08
If there's time at the end of this case review,
1:10
please join him in a q
1:11
and a session where he will address questions you
1:13
may have on today's topic.
1:15
Please remember to use the q
1:16
and a feature to submit your questions so we can get to
1:18
as many as we can before our time is up.
1:21
With that, we are ready to begin today's case review. Dr.
1:24
Mather, please take it from here.
1:27
Thank you very much. Uh, good afternoon to everyone.
1:30
It's an afternoon here in New Haven, Connecticut.
1:32
Um, not sure where people are joining from,
1:33
from across the world, but, uh, good afternoon to all.
1:36
I'm delighted to be here.
1:37
Truly an honor to be here
1:39
and, uh, excited to be able to share some cases with you,
1:42
uh, for the next hour or so.
1:44
So with that, I will share my screen.
1:47
So this is gonna be a GI GU case conference.
1:50
This is a snapshot of some of our, uh, trainees
1:53
and our program with some of the education leadership.
1:55
This is our, um, uh, our Yale mascot, handsome Dan, a big,
1:59
uh, this one is an inflatable dog,
2:01
and this is of course our Yale Medical School, um, uh,
2:04
picture of our Yale Med School.
2:05
And so today's gonna be GI G cases.
2:07
And the way I, uh, plan this out, there's gonna be 20 cases
2:11
and 20 GI ca uh, 10 GI cases.
2:13
10 GU cases, and they're gonna be
2:16
sort of interspersed throughout.
2:17
So it's not gonna be the first 10 or GI
2:19
and the, the second 10 or gu.
2:21
And we're gonna cover a bunch of different organs within,
2:23
uh, within those sections.
2:25
And, uh, as I said, there'll be, um,
2:27
an image or two that I'll show up.
2:29
We'll follow that up with a multiple choice question.
2:31
We'll have you guys, um, respond to that
2:34
and, uh, we'll go through the case together
2:36
and maybe I'll have some follow up questions as well, which,
2:38
uh, I'm happy for the audience to, to type in,
2:40
um, into the chat box.
2:42
So with that, let's go to our first case. Here we go.
2:50
I'm just gonna leave this up here for a few seconds.
2:52
Have a look at the case. What do we think is going
2:56
on as we go through this?
3:04
All right, now I'm gonna go
3:07
and provide you with the multiple choice options.
3:12
Over here. Should have a popup box.
3:21
What is the most appropriate initial treatment cystectomy
3:23
with ileal conduit creation, antibiotics
3:25
and Foley catheter drainage.
3:27
So is hitch sup pubic catheter placement.
3:36
All right, so we
3:41
see top answer antibiotics and Foley catheter.
3:44
And 68% no one picked a so
3:46
as hip, so people didn't like that.
3:47
Um, and then there was an even split between, uh,
3:50
some surgical options, cystectomy and, and aloc, conation
3:53
and SUP catheter replacement.
3:54
Perfect. So let's have a look at this case.
3:56
And, uh, the right answer is antibiotics
3:58
and Foley catheter drainage highlighted here in purple.
4:01
And so if we just look at this case, this is a plain film
4:03
of the, of the abdomen.
4:04
We can see, uh, an enteric tube over here.
4:06
And the real finding is centered around the pelvis.
4:08
You can see that there's almost this ring
4:10
of lucency around the pelvis.
4:11
And the question is, you know, what is that?
4:13
Um, and is that a normal finding? Is an abnormal finding.
4:16
If it's an abnormal finding, where is this located?
4:19
And this can be tough, you know, one can look at this
4:21
and think it's related to, um, a loop of bowel
4:24
and potentially air inside a loop of bowel,
4:26
which is called pneumatosis.
4:27
But the thing that lives down here in the midline
4:29
that has the shape, of course, is the bladder.
4:31
And when you see lucency surrounding the periphery
4:33
of the bladder like that, we need
4:35
to be worried about emphysema cystitis.
4:37
And, um, this is, uh,
4:39
and the treatment for emphysema cystitis is antibiotics.
4:42
Foley catheter drain, at least the initial treatment for it.
4:44
And so who gets emphysema
4:46
cystitis or what are the risk factors?
4:47
Diabetes is certainly one of them.
4:49
Anything that, uh, promotes urinary stasis,
4:51
whether it's a bladder outlet obstruction
4:53
or patients who can't, um, empty their bladder, say, uh,
5:00
am prone to getting emphysema cystitis,
5:02
there are certain bugs, the common bugs that cause
5:04
UTIs are the ones that can cause emphysema, cystitis.
5:07
You treat it with antibiotics, you try to drain it.
5:09
And, um, the key is to always, you know, sort
5:12
of differentiate this in your mind from emphysema pilon
5:14
nephritis, where you have this gas forming infection
5:17
of the renal parenchyma eating up the renal parenchyma
5:19
that often requires surgery, uh,
5:21
taking an, you know, the kidney out.
5:22
But this can be treated conservatively
5:25
with this sort of treatment.
5:26
And the other options, uh, that we talked about over here,
5:29
uh, you know, we, I haven't seen patients do cystectomy
5:32
or a supra pubic catheter placement for these.
5:34
Typically, uh, we'll do a Foley catheter
5:36
and just give antibiotics.
5:38
Um, certainly you can do, you know,
5:40
supra pubic catheter placement
5:41
for whatever reason if you can't do a Foley catheter.
5:43
But doing that as the first initial step
5:45
deemed a little bit too aggressive.
5:46
And then the so is hitch is sort of a procedure that's gone
5:50
to sort of re um, implant the ureters onto the so small, uh,
5:53
onto the bladder, which is, uh, sort of taken
5:56
and attached a little bit more
5:57
cephalad than it normally lives in.
5:59
So those are all surgical options wherein this needs
6:01
to be treated conservatively with the antibiotics
6:03
and Foley catheter drainage.
6:06
Perfect. And so with that, we'll move on to the next case.
6:13
Here we go.
6:22
So have a look. What sequence is this?
6:26
What modality is this? What plane are you looking at?
6:30
What organ are you looking at? What's the abnormality?
6:33
What do we think is going on over here?
6:40
For this one, I'm just asking you for the best diagnosis.
6:45
I've given you some mouthfuls there.
6:46
Adenomyosis, leiomyoma, adenomyosis,
6:51
intravenous leiomyoma, leiomyomatosis.
6:55
There you go.
7:07
All right, I love this.
7:08
So no one thought it was intravenous
7:10
leiomyomatosis, so that's good.
7:12
Somebody put myoma, maybe there's a, a fibroid in there.
7:14
Uh, but that's not probably the best diagnosis.
7:16
And then we got almost a 50 50 split between the two words
7:19
that sound very similar to one another.
7:21
So maybe the teaching point in this case is
7:23
how do we remember which one it is
7:24
when we look at it in real life?
7:25
So let's have a look. So, uh,
7:27
the answer is adenomyosis in this case.
7:30
And so the image
7:31
of course here is this al T two image of the pelvis.
7:33
We're looking at the uterus,
7:35
but we can see that the junctional cell looks very
7:37
indistinct, certainly looks indistinct posteriorly,
7:39
but anteriorly you can't even delineate it from
7:41
the adjacent myometrium.
7:42
So it's enlarged.
7:44
It looks indistinct to these tiny foci
7:46
hyperintensity T two signal within it.
7:48
This is a great look for adenomyosis, um, fibroids
7:52
that have more discreet discrete borders to it,
7:54
where you can actually take a, you know, uh, like a,
7:57
a pencil and sort of trace the, the outer border of it.
7:59
But you don't see that in this case.
8:01
Um, this is a good look for adenomyosis.
8:03
And so what do we need to know about adenomyosis?
8:05
It's the presence of endometrial clans
8:07
and stroma within the myometrium.
8:09
I sometimes think of this like endometriosis,
8:11
but involving the uterus itself.
8:13
And uh, you'll see a thickened
8:15
and lde defined junctional zone.
8:16
The number to remember is 12 millimeters in size when you
8:20
measure it, and you'll see hyperintense T two foci
8:23
that represents the endometrial glands
8:25
and sometimes the endometrial
8:26
glands could have hemorrhage in them.
8:27
So you'll see T one hyperintense foci in it as well.
8:29
In this case, I'm just showing you a T two weighted image.
8:32
And then how do you differentiate this word from adeno?
8:35
Mytosis? Adeno mytosis occurs in the gallbladder
8:39
and the one somebody taught me this many years ago,
8:42
and, uh, it always somehow stuck with me.
8:45
Gallbladder as a word, is a longer word than uterus.
8:48
Uterus is a shorter word, just like adenomyosis is a shorter
8:52
word than adeno mytosis.
8:54
And so somebody told me that one day about 15 years ago
8:57
and stuck with me and I've been, uh,
9:00
pretty good with remembering it.
9:01
Um, with that,
9:04
I think there is DIE case two,
9:09
oh, I don't know if I know what DIED
9:12
infiltrating endometriosis.
9:13
Is that what you're referring to?
9:15
That's 1D IE that I can think of.
9:17
If you wanna clarify that, that would be great.
9:19
Before I move on, you can do that in the chat
9:20
or, um, uh, or otherwise.
9:25
Oh yes. Okay. Yeah, it's possible. It's present.
9:27
Lemme just have a look. Um,
9:29
lemme just have a look over here.
9:32
I think based on these images,
9:33
it's really, it's tough to say.
9:34
I think what you could be referring to is this sort
9:36
of T two hypo intense signal there.
9:38
And I think absolutely that may, you know,
9:39
that's a good look for what, um, you know,
9:42
endometriosis could look like.
9:43
Uh, certainly in the, uh, in the,
9:45
in the cul-de-sac over there.
9:47
Um, I don't recall this patient had deep
9:49
infiltrating endometriosis.
9:50
That's a good observation. And,
9:52
and certainly one you'd have to sort
9:53
of see in different planes to, to figure out.
9:56
Perfect. So we answered that, answered that,
10:01
and we'll move on to our next mystery case,
10:17
the T two way image.
10:18
Do you wanna post contrast?
10:21
Hopefully we get a chance to look at it, figure out
10:24
what this abnormality is, where it's located.
10:26
And the question will be,
10:28
what do you wanna do next about this one?
10:31
Giving you mu multiple options to get a Whipples.
10:35
You can do a pet ct, you can do an endoscopic ultrasound,
10:39
and our facility, uh, GI docs end up doing that,
10:42
or you may be so confident to think that this is benign
10:46
and I could call it as such and no follow up needed.
10:48
So what does the group think about this?
10:58
Uh, this is, this is good.
11:00
I'm I, you know, listen, I, my ideally I'd have, you know,
11:03
I'm not somebody who wants to trick anybody.
11:05
I want everyone to get a hundred percent the right answer.
11:07
But it's also interesting to have a, a spread of answers to
11:09
so we can sort of understand what's going on.
11:11
I think this is a challenging case.
11:13
And so let's look at, see, uh, in this case, uh,
11:15
the right answer, um, uh, would be an endoscopic ultrasound.
11:18
Let's have a look and, and why that would be.
11:20
And so you look at this case, a T two 80 image.
11:22
We see a mass at the head of the pancreas.
11:24
It has lobulated borders
11:25
and internally it looks like it's composed of multiple,
11:29
multiple small cysts.
11:31
And, uh, we, we let post contrast image,
11:34
there are these thin septa that separate some of these cysts
11:37
and those end up enhancing
11:38
and it's located at the head of the pancreas over there.
11:41
And so what do we think is the best diagnosis?
11:43
Anybody can, uh, pop it up in the chat if they want to type
11:45
and, uh, flex their knowledge on what they think this is,
11:48
uh, given the imaging appears and what I've described.
11:55
Yeah, sist adenoma agree with, uh, uh, our, our,
11:59
our, our colleague there.
12:00
And so I think this is a great look for cyst adenoma
12:02
and I think that's probably what a lot of folks, um,
12:05
thought about exactly.
12:06
Pancreatic, scy, adenoma.
12:08
Um, the question then, uh, becomes, uh,
12:11
what do you do when you have something
12:13
that looks really classic for a sist adenoma?
12:16
And so we'll go through that in a second.
12:18
Let's talk a little bit about sist adenoma for those
12:20
who perhaps are struggling to understand
12:22
what this is in the first place.
12:24
This is a benign neoplasm that's seen, uh,
12:26
a little bit more often in females and,
12:28
and is often sort of used.
12:30
Uh, it is often, it, it can be challenging
12:33
to distinguish it from a munos adenoma,
12:36
both occur in females.
12:37
But remember that muus occurs a lot more commonly in females
12:40
at a ratio of six to one, whereas
12:42
serous is just a little bit more sys Adenomas tend
12:45
to occur in patients, um, who, uh,
12:48
are more than 60 years of age.
12:49
The majority of them, whilst musos adenoma a little bit
12:52
younger, 40 to 60 serous can occur anywhere.
12:54
But, um, some reports say it occurs preferentially in the
12:57
head, but I think the latest literature shows
12:59
that it really can occur anywhere.
13:00
Where am muus is generally body
13:01
and tail imaging appearance tends to be different.
13:05
S cystadenoma has a lobulated border multiple small cyst
13:08
that make it up, but 20% will have a central scar
13:11
muus the border will be nice and round.
13:13
Fewer cysts that look larger.
13:15
There is malignant potential fram malignant fra mucinous
13:19
or cys sist adenomas are benign.
13:22
And so the question becomes, what do you do with somebody
13:24
who has a, something that looks like a sist adenoma,
13:27
even though we know it's benign.
13:29
If you look at the guidelines, it turns out
13:31
that there is a lot of overlap between
13:34
what a serres adenoma can look like
13:36
and what some other pancreatic cystic lesions can be.
13:38
And so the best thing to do when you see somebody who has a
13:43
pancreatic cystic lesion that has high, you know,
13:46
the imaging period is a highly suggestive adenoma still need
13:49
to do the endoscopic ultrasound at least initially
13:51
to confirm that that's what you're dealing with.
13:53
Once you know that's what you're dealing with, you know,
13:55
you don't really need to do any further follow up
13:57
unless the patient is symptomatic,
13:59
in which case you can do an imaging follow-up
14:01
and potentially talk about reception.
14:02
But, uh, you do need to confirm it,
14:04
even though the imaging appearance can be classic.
14:06
There's a lot of overlap until that endoscopic ultrasound,
14:10
um, is critical in sort of, uh, cinching that diagnosis
14:13
of cy a no, let me just, uh, look at the chat box
14:17
and the quest q and a to make sure
14:18
that I've cleared everything.
14:20
Um, somebody said I'm not audible.
14:22
Hopefully I'm audible right now.
14:25
Um, and uh, you're good. Okay, perfect.
14:30
Maybe I, I, I, I muted out for a bit. I apologize for that.
14:34
Okay. And let me just see the other questions.
14:39
Did it show fat suppression?
14:42
I'm assuming that meant somebody's asking that.
14:44
I'm not sure which case that was.
14:46
It's referring to the pancreas case
14:48
and this, if it was that, you know, this, this, this,
14:51
this mass did not suppress with fat.
14:52
It does not contain any fat.
14:56
Alright, let's go to our fourth case.
14:59
Remember we got 20 cases, so we're, uh,
15:01
about a fifth way through this.
15:02
Now
15:08
for this one showing you a single image,
15:15
conventional radiograph.
15:16
Conventional radiographs are very tough.
15:18
It's hard to know what's going on.
15:28
And this one I'm asking the best diagnosis.
15:31
A couple of options here. SQL ulu, sigmoid ulu.
15:35
So Valase syndrome,
15:39
one of my favorite syndromes.
15:40
I haven't seen too many cases of that though.
15:41
Gallstone ileus,
15:49
what do we think?
15:50
Yeah, so this is good.
15:52
So I think, uh, most at sigmoid volvulus,
15:55
some said SQL ulu
15:57
and not too many were, um, enticed by the other options.
16:01
And so let me just look at, uh, the chat box to make sure
16:07
that, uh, we are good.
16:08
And so there was just some option, um, uh, chat about
16:11
what the diagnosis is.
16:13
And so this was, uh, a sigmoid vulu, which is, uh, uh,
16:18
the top answer, uh, that was suggested in this case.
16:20
And so what do we see over here?
16:21
So we're seeing basically, you know,
16:23
I say a conventional radiograph.
16:24
This really is a, a scout from a CT scan
16:27
that we eventually ended up doing on this patient.
16:29
And what we can see is that there's a large, uh, sort
16:32
of gas containing structure
16:34
that occupies much of the abdomen.
16:36
It has that classic coffee Bain appearance.
16:38
And if you look at sort of, you know, where it's pointing
16:41
to, it almost looks like it's pointing
16:42
to the right upper quadrant.
16:44
These are signs that are highly suggestive of sigmoid vis.
16:47
In this case, you can actually, uh, kind
16:50
of see the seum over here
16:51
and you can see the ileum over here
16:52
and you can see that that actually looks okay.
16:54
And so, um, you know, that's one way to exclude SQL vous.
16:58
SQL VOUSs, when it does occur,
17:00
often flips in the opposite direction so that most
17:02
of this occupies the left upper quadrant and the, you know,
17:06
and the, uh, sort of point of, um, direction the vector so
17:10
to speak, is sort of that left upper quadrant space.
17:13
Um, uh,
17:14
and it typically happens in younger patients as well.
17:17
Sigmoid vous on the other hand, older patients.
17:20
And, uh, there's all these signs that you can look for, um,
17:23
and you have this beak sign, this swirl sign
17:26
of the actual area of transition.
17:27
And remember, sigmoid VUL is in both sigmoid and SQL vs.
17:31
Are a type of large bowel obstruction.
17:32
And so you have twisting
17:34
of the mesentery resulting in that obstruction.
17:36
And, um, uh, you know,
17:39
I would say in real life it's sometimes challenging just on
17:41
x-rays to differentiate which one it is.
17:42
I think the important thing would be to figure out
17:45
that you're dealing with a ulous potentially
17:47
type configuration of the bowel.
17:49
You can always do a CAT scan to,
17:50
to sort out which one it is.
17:54
Uh, so let me just make sure
17:56
that we are clearing the chat box as we go along.
17:58
Perfect. Excuse me.
18:03
Let's go on to our next case.
18:11
We're shifting gears a little bit.
18:12
We saw a couple of conventional radiographs, we saw an MRIs,
18:15
now we move on to ultrasound of the right testicle,
18:21
gray scale image colored Doppler image.
18:23
We're seeing something there. Not subtle.
18:28
The question is, what do you wanna do about this
18:35
in your, in nucleation
18:38
orchiectomy biopsy?
18:43
Ablation?
18:57
Yeah, good.
18:58
So most people said nucleation,
19:00
which in this case is the right answer.
19:01
A few said orchiectomy, a few people said biopsy, um,
19:04
and some said ablation as well.
19:06
So let's just see, um, nucleation over here.
19:10
And so the key thing, this is sort of a, a two step, uh,
19:13
question in a sense in that.
19:14
Um, and the first thing is to, to understand
19:17
what diagnosis you're dealing with.
19:18
And you see this mass in the testicle.
19:20
It's clearly in particular mass,
19:22
but it has this classic appearance of, you know, sort
19:25
of onion, um, skinning
19:27
and, uh, sort of concentric circles
19:30
that are within this lesion is pretty well defined.
19:32
There's no flow within this,
19:33
just we couldn't detect it on color, color doppler imaging.
19:36
Uh, but certainly, uh, this is a classic appearance
19:39
for an epidermoid cyst.
19:41
This is a benign lesion
19:42
and, uh, it's essentially a cyst
19:44
that contains multiple layers of keratin
19:46
and the treatment is actually in nucleation.
19:48
And so the key thing in this case is to
19:51
identify prospectively that you're dealing
19:53
with a potential epidermoid cyst based
19:55
on this imaging appearance.
19:57
You relate that to urologists.
19:59
They do need to go to the operating room to take it out.
20:01
And once they confirm indeed
20:04
that this is an epidermoid cyst,
20:05
they do an nucleus just scoop it out.
20:08
Um, and that, uh,
20:09
prevents the patients from getting an orchiectomy,
20:11
which is a much more invasive treatment,
20:13
obviously taking out the testicle.
20:14
As far as I know, there's no rule for abl, there's no rule
20:17
for ablation, and this is not something
20:19
that we do a percutaneous biopsy on prior to that.
20:21
We actually do take into the operating room
20:22
and, uh, it is sampled in the operating room,
20:26
and if it comes back as epidermoids,
20:27
you scoop it out with an a nucleation.
20:29
If it comes back as, uh, a potential germ cell tumor, in
20:33
that case you'll do an orchiectomy.
20:34
And so they can only be alerted to
20:36
that possibility based on the read from the radiologist,
20:40
which is why it's really important to be able
20:41
to recognize this, um, when you're, uh, reading these cases.
20:47
Perfect. All right, case number six.
20:58
So CT scan, non-contrast.
21:04
Think about what we're seeing.
21:09
Excuse me,
21:15
what's the best diagnosis here?
21:18
Oh, we love these syndromes, don't we on hippo.
21:20
Linda, I'm giving you it all on hipa,
21:22
Linda neurofibromatosis, tuberous sclerosis.
21:26
Bert, uh, dubay, I forgot the accent on the e I'm sorry,
21:31
but I think it's dubay with the accent.
21:33
So what do we think is the best diagnosis
21:34
based on the images that we're seeing?
21:39
Good. So most people,
21:41
but two thirds thought it was tuberous sclerosis.
21:43
Uh, uh, uh, you know, there was, um, the folks,
21:46
some people thought it was Von Ilin, then there was a few,
21:49
uh, offerings for neurovirus and bird hog tope as well.
21:53
Uh, let me see the answer.
21:54
In the ua, someone wrote ms, which I'm not sure if
21:58
that's referring to, but I'll move on for the moment
22:00
and I'll, I'll go back to that at the end.
22:02
The answer this case is to scle. Good.
22:06
And so let's have a look at the images themselves.
22:08
So we have a non-contrast ct,
22:10
and if you haven't seen what the, you know, case of this
22:12
before, it can look really bizarre.
22:13
And so for junior trainees, you know,
22:16
I think a case like this can be quite challenging,
22:17
but if you've seen it, this is what they look like.
22:19
These are the kidneys and they are replaced
22:21
by multiple fat containing masses.
22:24
We can see that the containing macroscopic lipid,
22:26
it's almost hard to see any normal
22:27
renal parenchyma over here.
22:28
And when you see, um, kidneys that are replaced
22:31
with these types of masses, you really need to think of, uh,
22:34
uh, tuber sclerosis.
22:35
There's really almost nothing else
22:37
that can give you disappearance.
22:39
Uh, in this case. We can also see very subtly some tubing
22:42
that's coursing through portions
22:43
of the subcutaneous fat and peritoneum.
22:46
It's probably a VP shunt, as you know, patient
22:48
with supras sclerosis get
22:49
additional findings that we'll talk about.
22:52
And so what's, uh, we'll talk a little bit about an angio,
22:54
my lipomas first, these are fat continuing masses.
22:56
If you measure the house, phs usually be less than 20.
22:59
Uh, they don't calcify, they do calcify.
23:01
Uh, one would need to be suspicious that they potentially,
23:04
uh, are a fairly rare fat containing renal cell carcinoma.
23:08
It can happen, but those usually have fat
23:10
and calcium as opposed to AMLs which just have fat.
23:12
Most AMLs contain fat.
23:14
There'll be very small
23:15
percentage that are a little bit poor.
23:18
Mostl are just sporadic.
23:19
But when you have multiple bilateral, they're almost, uh,
23:22
always associated with the tuberous sclerosis.
23:24
They can rupture particularly when
23:25
they're more than four centimeters.
23:27
So we try to preemptively embolize them.
23:30
Now for tuberous sclerosis, what do they get in the kidneys?
23:33
The big flagship mass
23:35
that they get in the kidneys is the angiomyolipoma.
23:38
They can get cyst, they can get rccs
23:41
and that's fine to remember,
23:42
but just understand that the majority of them will get AMLs.
23:45
That's what you need to be worried about.
23:46
I'm not really looking for these other things in patients
23:48
with tuberous sclerosis, I'm looking for angio.
23:51
My lipomas von Hippel Linde on the other hand,
23:54
are the patients who get rccs.
23:56
They don't get angio.
23:58
My lipomas bird hog dubay, one
24:00
of the other options really rare,
24:01
but those patients end up getting rccs with lung cysts.
24:06
And so it's sort of a combination of, uh, of v hippo lindo
24:10
and, and, and tuberous sclerosis.
24:11
In terms of what things it, it gets
24:14
for tuberous sclerosis in the CN s they get cortical tube
24:16
subc, cortical appendamoma
24:17
that can sometimes cause hydrocephalus.
24:19
So you may see VP shunts in these patients heart
24:21
to get RDO myomas.
24:23
They get lung cysts, uh, called lamb abbreviation in,
24:26
in the lungs and bone islands.
24:28
Uh, they often get area bone islands in the bones.
24:30
And that's how I remember the sclerosis
24:33
part of tuberous sclerosis.
24:34
I don't think that's why it's called tuber sclerosis,
24:35
but I think it's an easy way to remember.
24:37
Look at the bones in patients tube sclerosis,
24:39
they'll often end up seeing these areas
24:40
of sclerosis, uh, bone islands.
24:42
Um, you know, in in their, in their, um, osteo structures
24:47
clinically, these patients present
24:49
with intellectual disability, seizures
24:52
and skin findings, the adenoma ation or the segre patches.
24:56
And if you present earlier on,
24:57
they end up doing poor prognosis
24:59
that if they present or oral prognosis than 3% later on.
25:01
So a bunch of things here about tubular sclerosis,
25:03
it's an important thing to know about.
25:04
It can come up in multiple organ systems
25:07
and one needs to really know this inside out
25:08
and be able to differentiate it from on HIPA Linde
25:11
and the more rare bird hog bay
25:13
neurofibromatosis doesn't get any of these things.
25:15
They just get these skin lesions
25:16
and neurofibromas elsewhere in the abdomen and pelvis.
25:20
So let me just make sure that everything has been answered.
25:26
Uh, some. Okay.
25:28
And someone still said ms, I wasn't sure what
25:33
that's referring to, but I will, uh,
25:36
unless you wanna put it in the chat box, I will move on.
25:39
Maybe it's multiple sclerosis.
25:40
If it is, this is not
25:42
what multiple sclerosis would look like.
25:44
Um, there's really not many abdominal findings that I know
25:47
of with multiple sclerosis,
25:48
unless they have secondary effects of uh,
25:50
say bladder dysfunction, you get a large bladder.
25:54
Okay, so move on
25:57
to our next case group is doing very well so far here.
26:02
I'm giving you some Mr images
26:04
T two T one post in different phases
26:08
and I want you to focus on this thing over here.
26:09
That's what I'm trying to show you.
26:16
Course. So
26:23
What do we think? This is
26:24
giving you some benign options,
26:27
giving you some malignant options.
26:29
I think it's important to, to be able to
26:35
diagnose this and be confident when you're diagnosing this.
26:37
So let's see, the group thinks,
26:42
let's see what the group group answers.
26:48
Yeah, 79% said hemangioma. Few people said others.
26:52
And, uh, let's talk a little bit about, uh, why those,
26:55
um, correct.
26:57
This is a angio, a nice example of I angio.
26:59
And so let's look at this lesion.
27:00
This is one we're gonna focus on here.
27:02
One of the key things in this case, it's
27:04
to look at the T two signal of the mass.
27:07
It's rather bright, right? It looks similar to CSF.
27:10
Whenever you see a mass that has signal,
27:11
that looks pretty similar to
27:13
CSF on the T two related images.
27:15
For the most part you're dealing with something benign
27:17
and you're really gonna be dealing
27:18
with other hemangioma or a cyst.
27:20
How do you differentiate between a hemangioma or cyst?
27:22
You give contrast cyst will not enhance hemangiomas.
27:26
Have a classic peripheral discontinuous areas of enhancement
27:30
that fill in as you go
27:31
through the different post contrast phases.
27:35
Now, on the other hand, if you see a mass in the liver
27:37
and it has the T two signal that's closer to say
27:39
what the spleen looks like, that's sort of evil gray look.
27:42
In that case, you're probably dealing
27:44
with maybe a primary tumor such as an HCC
27:46
or cholangio, maybe a met,
27:48
but potentially also things like FNHN, um, and adenoma.
27:52
So point is there that you could be dealing
27:54
with something benign or malignant,
27:55
but when you see something this, right,
27:56
you're almost always dealing with something benign.
28:00
Somebody says that the cases are easy.
28:03
Well, uh, I'm glad you find them easy,
28:05
but I think, uh, for some like
28:07
there are maybe learning opportunities.
28:08
So, uh, I'm glad to share those with the group.
28:12
And, um, uh, the only other
28:16
potentially malignant thing that can look this ttu right,
28:19
is a mucinous metastasis.
28:21
Metastasis from a primary mucinous neo, such as a mucinous
28:26
adenocarcinoma of the colon or the rectum.
28:29
Those can often have this T two bright signal,
28:31
but of course they won't have this sort of classic area
28:33
of enhancement and fill in like this.
28:36
And so what do we need to know about angios?
28:38
Well, we need to know what they look like for sure.
28:40
And this is a classic hemangiomas.
28:42
They can also be flash filling hemangiomas when they're
28:44
small because they're very common.
28:46
They're more often seen in females and they're benign.
28:49
And this is one of those things that we can say confidently
28:51
that this is benign and we don't need to worry about it.
28:53
Occasionally they can grow, uh,
28:55
but sometimes they can regress with, uh, with, in patients
28:58
who have cirrhosis and they can get a little bit smaller.
29:01
Bleeding for them is so, so rare.
29:02
There is a very rare syndrome called CAA backer syndrome
29:05
where hemangiomas, if they get really large
29:08
and in pediatric patients can sort
29:09
of cause a consumptive coagulopathy resulting
29:12
in thrombocytopenia.
29:13
And having patients prone
29:14
to bleeding can also cause high output,
29:17
high output cardiac layer.
29:18
In pediatric patients when they're very, very large
29:21
imaging findings can be diagnostic
29:22
to the point where no biopsies needed.
29:24
If imaging findings are classic,
29:27
somebody's asking about a sclerosis angio.
29:29
Now those sclerosis angios I'll answer right now,
29:31
are very, very tough to diagnose.
29:33
Sclerosis angios are gonna be those lesions that have sort
29:36
of slightly a, they kind of have some imaging features
29:38
of the hemangioma, but not all of them.
29:41
For example, you kind of T two bright,
29:43
but they won't have a classic peripheral discontinuous
29:45
enhancement in fillin.
29:46
They may have rim enhancement and some fillin
29:49
and you're really gonna be thinking about them in the
29:51
context of patients who have that bright T two signal.
29:53
Uh, with a little bit more atypical features.
29:56
The only way you diagnose it is sort of one of two ways.
29:59
Best way is that you have prior studies
30:02
from maybe many years ago showing
30:04
that in the same location there was a hemangioma
30:06
and now, uh, it, it sort of has this atypical feature.
30:09
So then you can call it sclerosis angioma.
30:12
The other way you do it is either just suspect it
30:14
and follow it up or you end up having a biopsy.
30:16
That's one of those things that is very tough
30:18
to call prospectively unless you haveli that showed an angio
30:21
with classic imaging features.
30:27
Alright,
30:35
two CT images, coronal, axial
30:38
and coronal in this patient who has a finding
30:57
best diagnosis.
31:05
Not sure if the, uh, answer has gone, uh,
31:08
the question has gone up for the group.
31:12
Yeah, it's launched. Okay, don't see it on my screen,
31:16
but that's perfectly fine.
31:24
Can you see are the results Dr. Mather?
31:27
I can't see the results. Mm-Hmm? Are they up?
31:29
They are up. Okay. Oh, I wonder where they went.
31:32
Let me see.
31:38
Hmm. Disappeared from my screen.
31:44
I can stop sharing. I can tell you I can stop sharing
31:46
and and sharing again. Maybe that'll help or
31:48
That, yeah, let's give that a try.
31:50
Okay, so let me do that again.
31:52
Sometimes these things happen.
31:54
Let me do one last thing before I share. Let me just,
32:08
okay, let's see.
32:10
I don't still see the answers up.
32:15
I will let you know the results of this one.
32:17
Yeah, and then maybe it'll correct for the next one.
32:19
That sounds great. So 26% pick the first option.
32:22
41% picked the second option,
32:25
31% picked the third option and 2% picked the last option.
32:30
Perfect. So we're really, you know, struggling
32:32
to an A, B, and C.
32:34
And so I think somebody
32:36
liked the last case 'cause it was a little bit too easy.
32:38
And hopefully they like this
32:39
case 'cause a little bit too hard.
32:40
This happens to be one of my favorite cases.
32:43
Um, and uh, I think somebody, uh, uh, yeah, so that's great.
32:47
So the answer over here is TREM roll desmoid tumor.
32:52
This is one of my favorite cases.
32:53
Now I actually think you can make this diagnosis
32:54
prospective, which is why it's one of my favorite cases.
32:57
Okay, talk a little bit about this case.
32:59
So everyone actually, um, correctly identified, uh,
33:03
the abnormality, right?
33:04
This is, uh, your mesenteric mass differential diagnosis.
33:08
We can see it over here, soft tissue attenuation
33:10
and has some ill-defined borders, maybe some speculations.
33:13
It's sort of centered in the mesentery.
33:15
And the question is, you know, you have this differential,
33:17
which I put up there, a desmoid tumor.
33:19
You have a carcinoid, nodal met, um,
33:22
retract on ENT neuritis, gossi oma sort of put in there.
33:25
Sometimes if you have routine surgical sponge,
33:26
it can cause this sort of reaction,
33:28
but nobody really thought that was the answer.
33:29
So let's put that aside. So
33:31
how are we gonna differentiate between these three?
33:33
That's sort of the, the, the crux of this question.
33:36
Well, maybe some observers noted
33:38
that there was something else missing in this case, right?
33:42
That's why I'm showing you the crawls.
33:44
I'm showing you the axial cts.
33:46
I don't see a colon over here.
33:48
Uh, maybe you say it's outta the field of view,
33:49
but I gotta tell you, you know, you're gonna have
33:51
to see a little bit of colon at this image.
33:53
You know, whether it goes in and outta the imaging.
33:55
I don't see anything here, nor do you see it here.
33:57
So this is a patient who's had a colectomy.
34:00
So patients who have colectomies, who gets colectomies,
34:03
sometimes patients with the ulcerative colitis
34:05
and also patients with familial adenos polyposis syndrome.
34:09
And, uh, that's part of the syndrome.
34:12
Um, patients in Gardner syndrome,
34:14
patients can't get desmoid tumors.
34:16
And so this is why, um, I think
34:18
potentially could get desmoid based on
34:20
the other ancillary features.
34:22
So, um, this is your differential for potential speculative,
34:24
esoteric mass desmoid happen post-surgery potentially.
34:27
Um, and also can be seen in the context of Gardner syndrome.
34:31
Carcinoid tumors tend to have, uh,
34:33
sometimes a few more flexive calcium,
34:36
a little bit more hyper enhancement associated with it.
34:38
Often it, you know, the primary tumor will be in the bowel.
34:41
So look at the adjacent lips of bowel,
34:42
see if there's any ileal, um, uh, primary tumors
34:45
retract mesenteries tends
34:46
to be a little bit more heavily calcified,
34:49
whereas this had no calc.
34:51
This is just a soft tissue mass.
34:52
And so, um, you know, there is sort of an overlap
34:55
of imaging appearance, but the key thing is to recognize
34:57
that colon is missing.
35:00
Um, uh, and when, and, and,
35:02
and those who, who were able to answer this, uh, correctly,
35:05
uh, may have seen that clue.
35:06
And, and, and kudos to you for doing so.
35:10
Alright, move on to our next case.
35:17
CT scan. I'm not sure if this is in the graphic phase,
35:22
it looks like it's probably a portals phase,
35:23
but we happen to end up having some contrast in the bladder.
35:25
But you know, there's a finding there and
35:36
I know we're radiologists,
35:37
but I'm gonna ask you for the histological diagnosis
35:39
of this finding and good.
35:41
I can see the case, the polls now, so
35:43
that, that ended up working.
35:44
So squamous cell adenocarcinoma, urothelial carcinoma,
35:47
small cell carcinoma.
36:08
One person said it, some people thought of squamous cell
36:12
and then most people urothelial carcinoma
36:13
and adenocarcinoma.
36:15
And you know, this is a tough one.
36:16
You know, maybe, maybe this, this question's a tough one
36:18
because, you know, common things being common,
36:20
this will probably end up being a urothelial carcinoma,
36:22
but the key is to recognize the location of this mass
36:27
and, um, and the internet.
36:31
Can, can you everyone hear me okay?
36:32
My internet connection said it was unstable Briefly.
36:35
Yeah, you were a little choppy. Okay,
36:37
But We hear you good now. Yeah.
36:39
Okay, good. So as I said, you know,
36:41
most people pick urothelial carcinoma and,
36:43
and you're right, in some sense statistically
36:45
that's probably the right answer.
36:46
But given the location of this mass
36:49
and the sort of appearance, one really needs
36:50
to think about adenocarcinoma, um, involving the UCUs.
36:55
And so let's have a look at this case itself.
36:57
So here we have a massive sort of the anterior aspect
36:59
of the bladder sort of situated in the bladder.
37:01
Do we actually see probably UCal diverticulum over here?
37:03
And this mass is sort of surrounding the
37:05
base of that diverticulum.
37:06
And when you look at that, you really need
37:08
to think of an adenocarcinoma.
37:09
There's really very few other contacts in which an
37:12
is gonna occur in the bladder.
37:14
Um, the other thing in this case you end up seeing is
37:16
actually carcinomatosis on some of these images.
37:19
Remember that adenocarcinomas in the ureas are very,
37:21
very aggressive tumors.
37:22
So, um, you may end up seeing, uh, you know,
37:25
widespread disease at the time with the diagnosis.
37:27
And so, which you do see in this case, often don't see
37:30
that in urothelial carcinomas,
37:31
even though there may be large masses in the bladder.
37:35
And so there's a bunch of, you know, uh,
37:37
range iCal abnormalities, whether it's a patent UCUs cyst,
37:40
diverticular, the sinus can get complications
37:43
with the diverticula including stone formation infection
37:46
and adenocarcinomas as well.
37:47
These tend to be a progressive aggressive tumors.
37:49
And so I think, uh, if I'd read this, I'd probably think
37:52
that that would be my favorite diagnosis,
37:54
this end up being an adenocarcinoma.
37:56
But to those who said urothelial, yeah, statistically,
37:59
you know, anything occurs on the bladders end up gonna be a,
38:01
it's probably gonna end up being a urothelial carcinoma.
38:03
And a question to the group
38:04
and you can feel free to chime in the chat box.
38:06
What are some risk factors, uh,
38:08
for getting squamous cell carcinoma of the bladder?
38:11
We get squamous cell carcinoma of the bladder.
38:14
Yeah, it's just a surmise.
38:15
So if someone, uh, answered that correctly,
38:18
and I think somebody, um, on the prior question,
38:20
how can we rule out carcinoma?
38:21
Hopefully I answered that correctly,
38:22
so I'm gonna say answered it live
38:24
and somebody's writing ra potentially
38:29
as an answer for something,
38:30
but I'm not sure if that's a abbreviation for something
38:33
that I don't know about four S's.
38:35
Okay, somebody wrote four S's, so probably smoking ESIS
38:40
and a couple of other S's there that, uh, to make up the,
38:43
um, the risk factors for for developing
38:47
squamous cell carcinoma, both SAP pubic catheter,
38:49
potentially SAP pubic catheter.
38:51
I, I would call this that as a, um, definite risk factor,
38:55
but I can imagine that a chronic indwelling supra pubic
38:58
catheter can cause enough irritation over a period of time,
39:01
uh, can develop squamous cell carcinoma.
39:03
You know, TB is not something I've typically heard
39:05
associated with squamous cell carcinomas though.
39:07
Um, I'm sure I, it's, it may be a possibility
39:11
and it's out there in the literature,
39:13
but that's, uh, I really do think it's just
39:14
a CIN is the big one.
39:15
That and smoking for squamous cell carcinoma. Good.
39:19
I think we're about halfway through,
39:20
so let's go move on to our next case.
39:23
There we go. CT scan, coronal axial,
39:28
hopefully a mass, not too subtle now we'll look,
39:33
think about what it is, think about where it is,
39:41
then ask yourself what is the best diagnosis.
39:46
I'm giving you some benign masses, some malignant masses,
39:50
some non masses hemorrhage and pseudocyst.
40:05
Yeah, general cortical carcinoma. Good.
40:07
Um, it probably this one may
40:09
have some areas of hemorrhage in it.
40:10
Uh, not a great look for pseudos.
40:12
We'll talk a little bit why I wouldn't
40:14
like this for adrenal adenoma.
40:15
I think, you know, again,
40:16
statistically any adrenal mass is gonna
40:18
end up being an adrenal adenoma.
40:19
But there's a couple of things here
40:20
that would sway me against that.
40:21
So let's have a look at this case a little bit more closely.
40:23
Answer adrenal cortical carcinoma
40:26
and even a large mass, right?
40:28
Very heterogeneous adenomas tend
40:30
not to be that heterogeneous, right?
40:31
They a little more homogeneous,
40:32
whether they're low intensity or higher intensity,
40:35
but very heterogeneous here.
40:36
High areas, low density areas.
40:38
I think the key thing is to look at the axials over here.
40:40
Look what this mass is doing.
40:41
This is the IVC, this is the left adrenal vein.
40:43
There's tumor that's eating away into this IVC.
40:45
There's tumor thrombus. Adenomas not gonna do that.
40:48
Certainly a pseudocyst is just a simple appearing syst in
40:51
the adrenal adrenal gland.
40:52
So that's not gonna be a hemorrhage.
40:54
Um, you know, our, you know, high density adrenal mass
40:58
that is often in the same shape as the adrenal gland,
41:00
but this you have a large mass heterogeneous innovating.
41:02
The IC this is gonna be an adrenal caral carcinoma.
41:07
And so that's what, uh,
41:08
I've mentioned here in some of the teaching points.
41:10
Most of these end up being non-functioning,
41:12
but if small proportion will be functioning
41:14
and those that are functioning a general cortical
41:16
carcinomas, they almost often present with Cushing syndrome,
41:19
Cushing syndrome that, uh, something that um, people like
41:24
to, uh, ask about.
41:27
And so that's something that the back of your, you know,
41:29
somewhere in the back of your mind
41:30
as you go through these cases.
41:37
Next case, single axial CT scan,
41:44
bizarre looking findings in the liver.
41:46
But it is what it is.
41:55
Here are your options. Best diagnosis.
41:59
I don't see, by the way, I'm not seeing the, um,
42:01
pole at this point, but I'm assuming it's launched.
42:04
Yes. Okay.
42:12
All the cystic liver disease s disease,
42:14
recurrent genic cholangitis and sclerosing cholangitis.
42:22
21% answered for the first one.
42:24
74% answered for the second option.
42:27
Um, and then 1% and 4% answered for the last two options.
42:33
Very good. I'm just gonna mute myself for two seconds.
42:44
Okay. There's a announcement overhead
42:46
and I didn't want that to, um, to, to get in the way of, uh,
42:49
of what I wanted to chat about.
42:51
So, great. So the top answer is Carli said, listen,
42:53
this is a very tough case, so I'm
42:54
really happy that everyone got this one.
42:55
Uh, the majority got it correctly.
42:57
And so this is coli's disease.
42:59
And um, so you notice a couple of things.
43:01
Uh, this happens to be a pediatric patient.
43:03
Look how small the C is.
43:04
The body's also quite small
43:06
and we're seeing multiple, um, low densities,
43:08
almost cystic appearing mass in the liver with, uh,
43:11
a beautiful thing right in the mineral.
43:13
What's the sign called?
43:14
You wanna chime in in the chat box of what the sign is,
43:16
what we're seeing in the middle
43:24
central dot sign.
43:25
Perfect. Yeah, it's exactly what it is. Central dot sign.
43:27
And that's classy for carles disease.
43:29
Uh, this is, uh, a ute in utero malformation of the ductal,
43:33
uh, of the ductal plate.
43:35
Um, these patients are at increased risk
43:37
for cholangiocarcinoma or just generally cholangitis
43:39
and infections within the biliary tree.
43:42
And you're end gonna end up seeing dilated intrahepatic bile
43:45
ducts, uh, which look very, very pronounced.
43:47
They manifest as the cystic spaces that surround
43:50
the, uh, portal vein.
43:51
So you get that central dot sign.
43:53
And so you can see that here on the
43:55
CT scan on this MIP image.
43:56
You can see how central portion
43:57
of the portal veins are going, you know, uh,
44:00
or the portal veins are going
44:01
to the central portions of this mass.
44:03
You can see beautifully here on this ultrasound.
44:05
And I also put this CT image here
44:06
because it has some associations with choal disease,
44:08
with abnormalities of the kidney.
44:10
So once you've seen
44:13
and suspected the patient has choal disease, you know,
44:15
to sort of finish off the case, look at the kidneys
44:17
and see if there's any cystic disease of the kidneys,
44:19
whether it's infantile, polycystic kidney disease,
44:21
or sometimes even mentally sponge kidney.
44:24
Uh, but this is a classic example
44:25
of cruelly disease target sign.
44:27
Somebody else said, yeah, central.target sign is, uh,
44:30
pretty much equivalent in my, uh, in my, my book
44:33
and somebody else has said central.in their webinar chat.
44:36
Perfect. Those are the cases of caroli disease.
44:38
The other options in this case, um, you know,
44:41
polycystic liver disease know you can think about that,
44:43
but they won't have that central dot sign.
44:45
Recurrent biogenic cholangitis is a disease
44:47
that preferentially occur, uh,
44:49
affects the left sided ducts causing ductal dilatation.
44:52
Um, and the next most common side
44:54
is the posterior right ducts.
44:55
And so that's sort of the distribution that we see
44:57
and sclero and cholangitis multifocal areas of beating
45:01
and uh, and dilatation, stricturing dilatation
45:04
of the intra extra patag bi tree.
45:06
They don't have this nice round cystic appearance in the
45:09
intrahepatic bile ducts.
45:12
Alright, and next case,
45:35
best diagnosis for this diver I'm giving you.
45:37
This is a diverticulum sanker killing Jameson
45:43
traction schizophrenic.
45:44
I don't see the answer box, so
45:46
I'm assuming the answers have launched.
45:49
Yes,
46:01
72% answered the first option
46:04
with 21% answering the second option.
46:07
Okay, so that makes up an even uh, 100. Very good.
46:10
The answer of course here is this sinkers dive reticulum.
46:13
Very, very good. And so, um, we look at this, this is, uh,
46:18
esophagus, we're looking at the, uh, top of the esophagus.
46:20
We see this sort of, um, contained collection of contrasts,
46:24
uh, rising on the cervical esophagus.
46:26
We could see on the AP view sort
46:28
of projects over the esophagus on the lateral view projects.
46:30
Posteriorly classic appearance of a sanker is diverticulum.
46:34
It's a type of pulsion diverticulum
46:37
and uh, there are several types of pul
46:38
and diverticulum anchors being one of them,
46:40
killing Jameson being the other one of them.
46:43
Zenker's his, you know, histologically goes
46:45
above the cricos line
46:46
through the killing dehiscence while killing Jameson occurs
46:49
below the killing dehiscence.
46:51
And when you look at killing Jameson diverticulum,
46:53
remember you're gonna best see it on the AP view
46:55
as something projecting laterally as opposed
46:57
to the zenker's diverticulum, which you see best on.
47:00
The lateral view is something projecting posteriorly
47:03
epi phrenic, which is one of the options of one
47:05
that occurs in the distal esophagus.
47:07
So we're really not dealing with that over here.
47:09
And then, uh, you can see
47:10
that the epi phrenic diverticulum here,
47:11
beautiful zenker's diverticulum over here killing Jameson
47:15
diverticulum projecting out laterally.
47:17
And then there's the traction diverticulum as well,
47:20
which is our fourth option, occurs at the meta esophagus.
47:23
And it's usually the setting of prior infection,
47:25
inflammation, surgery.
47:26
Often granuloma is disease in the mediastinum
47:28
that tugs the esophagus over a period of time
47:31
to create little focal out pouching.
47:33
So that's one that occurs in the mid esophagus.
47:35
So mid esophagus is traction in the context
47:37
of some mediastinal abnormality.
47:39
Distal esophagus is epi phrenic up
47:41
above his anchors and Killian Jameson.
47:43
And one needs to be able to differentiate them based on
47:47
where they project on, on ap uh, views.
47:50
And um, patient with zenker's can, for example,
47:52
with dysphagia, uh,
47:54
classic presentation is osis or bad breath.
47:57
And so that's another thing that, uh, patients are referred
48:00
to in the context when they're looking
48:03
for zenker's hyper reticulum.
48:07
All right, next case I've labeled these images for you.
48:11
T two, T one, pre T one fat s post
48:15
subtraction image down
48:21
Have a look.
48:29
Perfect. I can see case that's good.
48:31
It's case number 13, MHIC cyst endometrioma, two ovarian
48:36
germ and all things that can occur in the ovaries.
48:38
And that nexa, what do we think is the best diagnosis?
48:52
Yeah, so really, um, majority is endometrioma.
48:55
Uh, some, uh, next majority is the hemorrhagic cyst.
48:58
Dermoid is a possibility. That's a, a tricky one
49:00
for a dermoid actually, just based on the images I've given
49:02
you in then tube, ovarian aps correct answer
49:04
is endometrioma.
49:06
So here we see on the T two eight images bilateral, uh,
49:08
ovarian and nal masses, classic appearance FT two shading
49:12
as you go from top to bottom it gets darker.
49:15
T one pre fats that image, they look very bright,
49:18
not a good look for a dermoid, um,
49:20
because if it was, uh, fats that image over here,
49:23
these should be dark, but yet these are very, very bright.
49:25
So it's telling us it contains hemorrhagic content
49:27
and there's no enhancement over here.
49:29
Some people may argue there's something here
49:30
and you would be correct in that observation,
49:32
but I'll tell you, um, this panned out to be nothing.
49:35
I think it was just volume averaging of something like that.
49:37
So this is no essentially no enhancement within this lesion.
49:40
There's no inflammatory change around this suggests tube.
49:43
Ovarian abscess and hemorrhagic cyst is a possibility,
49:45
but you seldom see that beautiful T two shading
49:48
because um, you know the, the reason you see T two shading
49:52
of course is because you have repeated bouts of hemorrhage
49:54
that give you different gradations of blood within that,
49:57
you know, within that mass as opposed
49:58
to hemorrhagic cysts which just comes
49:59
and goes over a period of time.
50:01
So you don't have that classic T two shading.
50:04
Bonus question for the group.
50:05
What are the cancers that are most classic associated
50:08
with endometriomas?
50:10
Type it in the chat box if you want.
50:22
Endometrioid. Yep. Love that one.
50:23
There's another one that's also classic for it.
50:25
If anybody knows
50:31
someone said a, so maybe prematurely type
50:34
that in, but let's go through it.
50:36
Um, and so this is a case of endometriosis.
50:39
Yeah, clear cell. Perfect, perfect.
50:40
And so endometriosis, we've talked a little bit about some
50:43
of the imaging signs that we look for.
50:44
We also look for adhesions by the way
50:46
that can occur in endometriosis.
50:47
It can occur to deposition
50:49
of the stromal tissue in the a nexa
50:51
and uh, sometimes their scarring
50:52
as a reaction to some of that.
50:53
So look for adhesions,
50:55
you have the classic kissing ovary sign
50:56
that pull the ovaries together.
50:58
Um, somebody also talked about endometriosis, one
51:00
of our prior cases with adenomyosis, uh,
51:03
where we saw some stuff in the cul-de-sac.
51:04
That was T two IBO intensive. Of course these are the
51:06
associated tumors that one needs to look for.
51:09
Recently we've seen cases of tumors associated with these
51:11
and all you're looking for is soft tissue enhancement
51:13
associated with something that otherwise looks like
51:15
it endometrioma.
51:17
Somebody said chocolate. That's the classic thing you see on
51:19
uh, on laparoscopy and um,
51:22
and others have answered in the chat
51:23
box in terms of the, the cancer.
51:25
So perfect.
51:29
Next case, HSG.
51:45
Which of the followings are risk factor for developing
51:49
whatever disease you thought about
51:50
that I showed you on the prior prior C-section?
51:53
Endometriosis, PID
51:55
or just getting a, excuse me, getting a prior HSGI
51:59
don't see the answer options, but I'm assuming they're up.
52:04
Oh, there we are. Now they're gone again. Oh, here we go.
52:09
Perfect. Pelvic inflammatories. Okay, perfect.
52:11
So, um, a few people said some other things,
52:14
but vast majority of pelvic inflammatory.
52:15
So before I give away, uh,
52:18
talk a little bit more about this,
52:19
what disease are we actually dealing with?
52:20
Just wanna make sure we're all on the same page.
52:22
So you can put in the chat box or in the q and a
52:35
perfect sin.
52:36
That's good enough. It's too long
52:38
to type out in its entirety.
52:39
This is a case of uh, a rare thing.
52:41
I haven't seen too many cases Sal meningitis, ISA and OSA
52:45
and um, this really amounts to,
52:48
well the imaging appearance is really these small
52:50
diverticula, these outpouching
52:52
that extension from the fallopian tubes typically in the
52:54
proximal portion of the fallopian tubes, um, can
52:58
and uh, it is often bilateral seen up to 80%
53:02
of patients and one clear association of the history
53:04
of prior pelvic inflammatory disease.
53:07
Clinically, these patients may manifest with, uh,
53:10
infertility or ectopic pregnancies
53:12
and there is a differential for this,
53:14
but you know, I don't think one needs
53:16
to remember this disease are so rare,
53:17
including this disease, which is very rare.
53:20
But um, I have this image from STAT dx,
53:22
which I thought was really nice that really show why you
53:25
know, what happens from a, from a sort
53:27
of a drawing perspective to have
53:28
that translates to what you're seeing.
53:30
So because of the PID as one of the prime risk factors,
53:33
you get thickening of the fallopian tube
53:34
and you get these little out pouching that sort of form
53:36
inside this area of thickened fallopian tube.
53:38
And these are the ones that fill with contrast
53:40
manifesting in these diverticula.
53:41
Uh, in some sense this is um,
53:44
almost looks like adeno mytosis in the gallbladder
53:46
fundus right that we see.
53:47
But this is actually in the a fallopian tubes
53:49
and it's called esophagitis ISA osa.
53:52
Perfect. And so I'm just looking at the chat box
53:54
to make sure that we are on top of that.
53:59
So good on the group for getting that move on
54:02
to case number 15,
54:10
Yellow arrow in this case.
54:12
'cause as I realized as I put this together
54:14
that you may be looking at other things over here,
54:16
so I wanted to make sure
54:17
that you were looking at the right finding.
54:18
And the question is, in this case,
54:22
what's the next best step?
54:24
So this obviously requires you to make the finding,
54:26
figure out what it is and then give an option.
54:30
So you have options including pet ct ultrasound,
54:34
surgical resection where you can be bold,
54:38
say no further follow up.
54:44
So I don't see the answer options
54:47
nor the answers for what it's worth. So
54:51
Nine, three, uh, excuse me, 9% answered PET ct 39%.
54:55
Okay, perfect. Answered I see ultrasound,
54:57
I'm seeing that, I'm seeing them now, so that's great.
54:59
Okay, perfect. Thank you so much.
55:00
Yeah, maybe this just bit of a delay.
55:02
I apologize maybe on my end. It's okay.
55:04
So there's a bit even between
55:05
ultrasound no further their follow up.
55:06
Yeah, so you know,
55:08
question really is what is this represented?
55:09
Somebody had already, uh, kindly uh, put in the chat box,
55:12
adeno mytosis, we know how
55:13
to differentiate it on adenomyosis.
55:15
Now another a case that we saw earlier today.
55:18
Um, and so this one I'd say no further follow up.
55:22
I feel pretty good that this is adeno mytosis.
55:24
I know these are benign things and
55:25
I really don't wanna do anything else.
55:27
And so adeno mytosis is benign, but it's important uh,
55:31
because it's common and sometimes if it looks
55:33
atypical may mimic cancer.
55:35
But what ends up happening, um,
55:37
I suppose I didn't realize I put this right
55:38
after my uh, celling isma osis slide,
55:41
but you get hyperplasia at the epithelium in these little
55:43
um, uh, mucosal imaginations that sort
55:46
of protruded into that area.
55:48
These perform these diverticula
55:50
that called world ash cuff sinuses.
55:52
And you may have, you know,
55:53
because of the stasis here, biliary crystals that deposit,
55:56
um, it can be focal segmental,
55:58
diffuse often it can be, uh, focal.
56:01
And it has this classic appearance on Mr,
56:03
where you have a string of pearls, T two hypertensive foa
56:05
that are just clustered next to each other on the uh,
56:08
gallbladder fundus.
56:09
When I see this, I don't need an ultrasound to prove it.
56:12
In fact, to me it's easier to call on these MR than it
56:14
is on the ultrasound at times.
56:15
You know, this is not a good look
56:17
for a malignancy of any sort.
56:19
And so, you know, you see this
56:21
not uncommonly I I mentioned in my report.
56:24
I wouldn't recommend further follow up if there are any
56:27
atypical features which are often, by the way, sometimes,
56:32
uh, seen on CT scans where
56:34
you don't see the actual cystic foci.
56:36
It just looks like soft tissue thickening.
56:37
In that case I would maybe get an MRI or an ultrasound.
56:39
But on MRI now if it looks like this, it's quite clear
56:42
that you're dealing with adenomyosis
56:44
and you would need a follow up for it.
56:50
Okay, wrapping up last couple of cases here.
56:58
I dunno if I have another image over here,
57:00
but I'll just keep with that for the
57:02
moment and maybe I have another image.
57:04
May have a misplaced animation.
57:11
There we go. Coronal CT as well.
57:17
Axial ct.
57:23
Best diagnosis for this case please.
57:26
Mucosal infected mesh plug diverticulitis. Lymphocy.
57:46
Yeah, 66% said mucosal.
57:48
A few others said other things, but looks like uh,
57:50
the goop knows what they're dealing with over here.
57:53
Um, let, just see.
57:55
Make sure 13 millimeters with cancer
57:58
and PMP.
58:01
I'm not what that's referring to,
58:03
but we can certainly go back to that.
58:05
So the answer here is in muco cell.
58:06
So what are we actually looking at here?
58:08
Abnormal in the right lower quadrant, a tubular mass,
58:11
low in density, peripheral calcifications,
58:13
you know this is gonna be a mucosal, uh, mesh.
58:16
Plugs can be placed for inguinal hernia.
58:17
Appears they're gonna occur more triangular in shape.
58:20
And right in the inguinal canal.
58:21
Um, you know, diverticulitis, uh, you know,
58:24
I don't see any inflamm diverticular area on lymphic seals
58:27
or lymphatic malformations can look fluid in density,
58:30
but, uh, usually not mass like,
58:31
and, um, don't often have
58:33
that classic peripheral calcifications.
58:36
Um, oh yeah, pseudo oma. Yes, uh, that's what somebody said.
58:39
Now and certainly when these things pop
58:41
or they spill over, they get pseudo oma peritonitis,
58:43
which you get this gelatinous mucin appearing
58:45
ascites all over the body.
58:47
Um, in this case, is there a mass?
58:48
Tough to say, I don't see a mass in this case, but, um,
58:52
but certainly, uh, one thing to look out for is the mass.
58:55
What we can say with confidence that
58:57
what you're dealing with is a mucosal.
58:58
Uh, there's a number of things that can cause it
59:00
to become a mucosal, including a mass.
59:02
And you really need to look carefully with a panic, scenic,
59:04
soft tissue nodules to suggest, uh, the presence of a mass.
59:08
When you see this, this does need surgical resection,
59:10
often more than just appendectomy, right?
59:12
Hemic colectomy. Um,
59:14
and so that's the importance of being able to diagnose this,
59:17
uh, prospectively to guide our, our surgical colleagues.
59:23
Right? Next case I'm showing you Mr.
59:27
Images T two weighted
59:32
post contrast image
59:37
abnormalities in the right kidney.
59:47
And I'm asking you, 'cause you did so well last time,
59:50
figure out the histology for this neoplasm.
59:54
Clear cell papillary
59:58
medullary squamous cell.
60:10
So I'm not seeing the popup box,
60:13
so I'm not sure if it's been answered already,
60:14
but you can guide me to, to let me know when that's,
60:16
that's been answered.
60:18
Sure. 33% said clear cell.
60:20
Okay, 47% said papillary, 16% said manary. Okay.
60:25
And 4% said squamous cell.
60:27
Perfect. Thank you very much.
60:29
And to the majority I think got this answer correctly,
60:31
but there was a bit of a spread
60:33
and to the correct answer in this case
60:35
that's I would say was a papillary renal neoplasm.
60:37
Um, and somebody asked something about the
60:40
mucus, answer that in a second.
60:42
And so what are we actually seeing over here?
60:44
And so here we're seeing a mass in the right kidney,
60:47
relatively T two hypo hypo intense and there is enhancement,
60:52
but it's not very brisk enhancement.
60:53
This is what we call low level enhancement.
60:55
Most clear cell carcinomas will have much brighter T two
60:58
signal and much more brisk enhancement.
61:00
And whereas it is the most common histology,
61:03
this is not a great look for it papillary on the other hand,
61:06
this is a great look for it.
61:07
It has that low T two signal low level enhancement
61:09
and so I would favor that medullary.
61:12
Not a great look for medullary by the way.
61:14
Who gets medullary carcinomas of the kidney.
61:16
People can chime in the chat box.
61:17
There's certain demographic factors
61:19
that make patients at risk for that.
61:21
Does anybody know?
61:26
Yeah, sickle cell trait make sickle cell trait.
61:30
Sickle cell trait. Exactly.
61:31
And so, um, uh,
61:35
and so in this case, uh, uh, you know, there's,
61:38
I didn't give you the history of sickle cell trait.
61:39
You really do need to have that history of it.
61:40
By the way, patient in a couple of cases,
61:43
they have very aggressive tumors.
61:45
They're young patients with very aggressive tumors
61:47
that are very infiltrative in their appearance.
61:49
Don't have these nice around borders like this
61:51
and often have widespread metastasis.
61:53
A time of diagnosis including adenopathy liver mets.
61:56
Um, so this is not a great look for it.
61:58
Squamous cell carcinoma of the kidney, very, very rare.
62:00
There is one condition that I know of
62:03
which is associated squamous cell carcinoma with a kidney.
62:05
Anybody know what that is? Chime in the chat box.
62:20
Somebody's putting it in. Yeah, very good.
62:22
I think you spelt that a little incorrectly,
62:23
but you are correct Exis, Carbin is pyelonephritis.
62:26
And so that's the only one that I know of that as,
62:28
as an associated with squamous cell caroma.
62:29
Very, very rare. So
62:31
as I talked about, there's different subtypes.
62:33
These are the three most common clear cell
62:34
and papillary could potentially diagnose prospectively.
62:37
Um, in general, when you see a mass in the kidney's,
62:40
T two hypot intenses, your options are papillary cyst debris
62:44
or Lipitor ml cystic debris has no enhancement.
62:47
Papillary is low level enhancement.
62:49
Lipitor AMLs, what we've talked about AMLs
62:50
before, only about 5% are lipid poor.
62:53
They can look quite T two hypot intenses,
62:55
but they tend to have avid, avid enhancement,
62:57
whereas this doesn't.
62:58
And so that's one way to potentially differentiate it.
63:00
Sometimes it's tough for me to biopsy it,
63:02
but those are some clues we can look at to figure that out.
63:06
Somebody asked about percentage of calcification mucus cell.
63:08
You know, I don't have the uh, answer to that.
63:10
Um, but um, you know, I I certainly not all
63:14
of them do calcify, but it's a classic sign of,
63:16
of a mucus seal that when they do have some peripheral
63:18
calcifications, how can we differentiate from a hemorrhagic
63:21
cyst presence or absence of enhancement?
63:23
And in terms of enhancement, uh,
63:26
when something does not enhance, it looks black,
63:28
it looks dark, it looks like the stuff over here,
63:30
completely black over here,
63:31
but this has a little gray
63:33
enhancement, low level enhancement.
63:35
So even that little amount tells us that it's enhancing
63:37
and that it represents a papillary RCC as opposed
63:40
to a hemorrhagic cyst.
63:45
Next case over here, I think we are almost done.
63:47
We have one or two more cases to go
63:52
gray scale and colored doppler image.
64:02
We have repeated some slides here. I apologize.
64:05
Next best step. So giving you
64:10
some benign options, antibiotics,
64:12
giving you some more aggressive options,
64:13
giving you some imaging, follow-up options,
64:15
which is always a possibility.
64:24
Perfect. 88%. Yeah.
64:26
So what we're dealing here, clearly the group knows
64:29
is EPI ide.
64:30
So we see the tail of the epidem here, enlarged,
64:33
heterogeneous, vascular, um, you know, there's a couple
64:37
of clinical signs that can be associated with it
64:39
and the bugs you're dealing with when it's above the age
64:40
of 35, typically e coli, uh, due
64:43
to retrograde infection from the bladder when it's less than
64:45
35 to sexually transmitted infections
64:47
tend to be a little bit more common.
64:48
Regardless, you need to be treating it with antibiotics.
64:50
There are some non-infectious etiologies, um, much,
64:54
much less common such that it's not even worth, you know,
64:57
really remembering these, these things being so common.
65:00
Uh, you're dealing with epi, somebody asked about the prior
65:04
case, but T one hypertense content
65:06
and hemorrhagic is certainly,
65:07
if you see T one hypertense content,
65:09
highly suggest hemorrhagic is,
65:10
I find it's variable sometimes can be T two hypo
65:13
right on one weighted images.
65:14
So just having that is not a great clue.
65:17
I think it's the, the lack of enhancement
65:19
that to me that helps the most.
65:27
Next case,
65:36
CT scan.
65:37
Hopefully the finding is not subtle.
65:41
What are we dealing with here?
65:45
Clearly a fat containing thing,
65:47
but which version of a lipos sarcoma?
65:50
An A MLA myeloid lipoma or a lip best diagnosis?
66:01
Yeah, lipos sarcoma.
66:02
So I'm liking the way we're ending here
66:04
with people all on the same page as being a lipo sarcoma.
66:07
Listen, this is a, a large fat,
66:09
fat containing masses in the retro repair
66:10
and look out to pushing the kidney upwards.
66:12
Um, and the well differentiate ones will have some septal
66:15
which are thinner minimally, uh, thickened,
66:17
minimal nodular components.
66:19
Um, I think there should be less than one centimeter
66:21
as opposed to greater than one centimeter,
66:22
but it does have mass effect.
66:24
Well, differentiated ones are low grade, no metastases,
66:27
but if you do resect them, they can have local recurrence.
66:29
Um, angio my lipomas.
66:31
You know, you know, in theory it can look like this,
66:33
but you want to see sort of a claw sign of,
66:35
or um, a sign any sign that it's sort
66:37
of arising from the kidney, in which case you don't.
66:40
My lipomas occur in your adrenalin gland.
66:42
This is not super renal and lipomas, by the way,
66:44
in the retroperitoneum are so rare such
66:46
that even if you see a beautiful FatCat contain mass without
66:48
any complexity, you're still gonna be thinking
66:50
that I'm dealing with a well differentiated lipo sarcoma
66:53
as opposed to a plain old lipoma.
66:57
In the last case, I believe
67:03
give you 10 gi 10 G wanted to cover as many organs
67:07
as I could and I had to give you one spleen, one to end.
67:09
So here we have a splenic mass, you see it here,
67:15
post contrast image out of phase image
67:17
and endphase image trying to show you something here
67:30
as diagnosis
67:35
lymphomas sent
67:37
hematoma splenic infarcts.
67:50
And so, so this is a tough one.
67:52
I I found it very difficult to write the question
67:54
for this one because, um, you know, uh, you know,
67:59
s san even if you don't know what it is,
68:00
if you look at these other options, you may pick it out
68:02
of a, you know, of exclusion
68:03
and this turns out to be a, a santi was resected.
68:05
Lemme see what the question is here San, somebody answered
68:07
that, that perspective really good for you.
68:09
Um, and so what's a san,
68:11
so san sclerosing angio oid nodular transformation
68:15
of the spleen is rare, sort of recently described.
68:18
Uh, lesion often is incidental.
68:20
And what are the imaging features that you're gonna clue you
68:23
and that you may be dealing with ascent?
68:24
Well, first of all, you're gonna be dealing
68:25
with an isolated splenic mass pretty well circum,
68:28
so nice uh, definable border
68:31
often has hypo intense T two signal
68:34
because it's a relatively vascular lesion
68:36
and that can undergo internal bleeding.
68:38
When it does enhance, it has, uh,
68:41
spoke wheel type enhancement within it.
68:43
And what I was trying to show, core example
68:46
of it in this case was in the in
68:48
and out phase images was, um, hemo,
68:50
citrin deposition a little bit on the endphase image.
68:53
It's a little bit dark over there
68:54
because of that uh, uh, presence of hemorrhage.
68:57
This is not a great look for lymphoma.
68:58
Lymphomas without treatment don't really have this
69:00
heterogeneous signal heterogeneous enhancement.
69:03
Um, although lymphomas can occur in the spleen,
69:05
this is just not a great look for it.
69:07
Infarcts don't enhance, hematomas don't enhance.
69:10
And so those would not be a good look for that.
69:12
The other thing that comes up, it's a rare tumor
69:14
that sometimes can be, you know, miscon confused
69:17
with this one is, uh, literal cell angioma
69:20
and the one key differentiating feature
69:22
that I always remember, literal cell angioma versus ascentis
69:24
sans are isolated, tend to be solitary.
69:27
As for solitary razan, literal cell cell angios tend
69:30
to be more multiple and smaller in size.
69:34
Hematoma could look similar, you know,
69:36
'cause these things, you know, in spleen it's, it's not
69:38
as easy as other organs, um, to,
69:40
to call things prospectively.
69:42
But I would say that the T two signal generally is
69:43
not as dark at a hematoma.
69:45
Usually more intermediate looks similar to the spleen.
69:48
Hemangioma tend to be brighter.
69:50
What's I think, unique about this is
69:51
that relatively dark T two signal spoke wheel enhancement
69:54
and hemo citrine deposition.
70:00
How is sand managed? That's a great question.
70:01
It's benign things. You could potentially just follow it.
70:04
Um, but sometimes, uh, you know, certain patients, uh,
70:07
because you can't call it prospectively what you know,
70:10
we don't know prospectively what it ends up being.
70:12
They may need to do a splenectomy,
70:13
but it's reasonable to follow it over a period of time,
70:15
maybe for six months for a while, then yearly just
70:18
to make sure that it doesn't grow.
70:20
Certainly the symptomatic you're gonna have to take it out.
70:25
I haven't heard of cases someone's asking if San can rupture
70:28
spontaneous cause placebo, peritoneum.
70:29
I haven't heard, um, of, of, of it doing that.
70:33
There may be case reports, but that's not something
70:34
that's really associated with, with sand tumors.
70:37
Uh, in terms of endometriomas the best treatment,
70:39
I mean not much to do.
70:41
Uh, you know, if the patient has a lot of symptoms,
70:43
I know they can sometimes go in and,
70:45
and sort of do an ovarian cystectomy
70:47
and take out the endometriomas,
70:48
but uh, it's usually just hormonal treatment
70:51
and symptomatic treatment.
70:52
Um, oftentimes they don't wanna do much surgery
70:54
with endometriomas 'cause already
70:55
so many adhesions if you go in there,
70:57
it's gonna cause more damage.
71:01
Perfect. And threw out the chat box and q and a.
71:04
I know I kept you the group a little bit over,
71:05
so I apologize for that, but hopefully this was useful.
71:08
Um, personally I'm not used to doing a lot
71:10
of multiple choice type of conferences.
71:12
I, I love the sort of the oral format where you can engage
71:15
with an audience, uh, in that manner.
71:16
But I really appreciate the engagement in this matter.
71:19
All the questions and I'm happy to sit around
71:21
for a few more minutes, uh, if anyone needs
71:23
to, to reach out to me.
71:29
Thank you so much Dr. Mather for that great case review.
71:32
Even though you don't do multiple choice questions a lot.
71:33
That went great. Appreciate it.
71:37
I'm quickly looking through the chat
71:38
to see if there's any other questions that came up.
71:41
Lots of thank yous.
71:45
Lots of, yeah, I think you covered everything.
71:48
Somebody asked about mucinous mets on liver.
71:50
MRI uh, mucinous liver mets on TW.
71:52
Yeah, mucinous lesions tend to not have that.
71:55
Nice um, beautiful restricted diffusion can, you know,
71:59
it's good to sort of pick up on the
72:01
lesions 'cause they'll all appear bright.
72:02
But if you look at the A DC, you may not end up seeing, um,
72:05
the dark, uh, thing on a DC images.
72:08
And so you really have to deal with, you have to interpret
72:11
that image in the context of the tumor that you're dealing
72:13
with, which is the mucinous primary as well
72:15
as the T two image appearance
72:16
and the post contrast appearance.
72:19
Well, I think we will wrap things up.
72:21
Thank you so much again Dr.
72:22
Mather, for this great case review
72:24
and for everyone else for participating today.
72:27
Wonderful. Thank you everybody.
72:29
You can access a recording of today's conference in all
72:31
our previous noom conference
72:33
by creating a free MRI online account.
72:36
And be sure to join us next week on Thursday,
72:38
May 30th at 12:00 PM Eastern, where Dr.
72:41
Demetrios PRUs will deliver a lecture entitled a deep dive
72:45
into PSMA PET Interpretation
72:48
you can register for@mrionline.com
72:50
and follow us on social media
72:52
for updates on future NOOM conferences.
72:54
Thanks again for learning with us and have a great day.